{"slideshow_credits": null, "snippet": "Sun Pharmaceutical Industries, the Indian drug maker, said on Sunday that it would pay about $4 billion in stock for Ranbaxy Laboratories, a smaller Indian rival.", "abstract": "Sun Pharmaceutical Industries, the Indian drug maker, said on Sunday that it would pay about $4 billion in stock for Ranbaxy Laboratories, a smaller Indian rival.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/04/06/sun-pharmaceuticals-of-india-to-buy-ranbaxy-a-smaller-rival/", "lead_paragraph": null, "headline": {"main": "Sun Pharmaceuticals of India to Buy Ranbaxy, a Smaller Rival", "kicker": "DealBook"}, "_id": "5341f6d438f0d82e0d98dffe", "word_count": "248", "multimedia": [], "pub_date": "2014-04-06T20:51:48Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Ranbaxy Laboratories", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}